Pteroside A

Pteroside A
Product Name Pteroside A
CAS No.: 35910-15-7
Catalog No.: CFN80184
Molecular Formula: C21H30O8
Molecular Weight: 410.19 g/mol
Purity: >=98%
Type of Compound: Sesquiterpenoids
Physical Desc.: Powder
Source: The herbs of Pteris aquilinum
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price:
Reference standards.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Anticancer Res.2021, 41(3):1357-1364.
  • Molecules.2020, 25(21):5087.
  • Plants (Basel).2021, 10(11):2317.
  • J Pharm Biomed Anal.2016, 129:50-59
  • Microb Biotechnol.2021, 14(5):2009-2024.
  • Front Immunol. 2020, 11:62.
  • J Nat Med.2017, 71(4):745-756
  • Plant Foods Hum Nutr.2020, 10.1007
  • Journal of Ginseng Research2019, 10.1016
  • Nutrients.2023, 15(13):2960.
  • Pterosin D

    Catalog No: CFN98443
    CAS No: 34169-70-5
    Price: Inquiry(manager@chemfaces.com)
    Pterolactone A

    Catalog No: CFN96247
    CAS No: 74730-10-2
    Price: Inquiry(manager@chemfaces.com)
    Pteroside D

    Catalog No: CFN98485
    CAS No: 35943-38-5
    Price: Inquiry(manager@chemfaces.com)
    Pterosin D 3-O-glucoside

    Catalog No: CFN97608
    CAS No: 84299-80-9
    Price: Inquiry(manager@chemfaces.com)
    Epipterosin L

    Catalog No: CFN98865
    CAS No: 52611-75-3
    Price: Inquiry(manager@chemfaces.com)
    Epipterosin L 2'-O-glucoside

    Catalog No: CFN97719
    CAS No: 61117-89-3
    Price: Inquiry(manager@chemfaces.com)
    Norpterosin B

    Catalog No: CFN96799
    CAS No: 1226892-20-1
    Price: Inquiry(manager@chemfaces.com)
    Norpterosin B glucoside

    Catalog No: CFN89000
    CAS No: 1226785-88-1
    Price: Inquiry(manager@chemfaces.com)
    Pterosin B

    Catalog No: CFN96798
    CAS No: 34175-96-7
    Price: Inquiry(manager@chemfaces.com)
    trans-Norpterosin C

    Catalog No: CFN96609
    CAS No: 64890-70-6
    Price: Inquiry(manager@chemfaces.com)
    J Nat Med. 2008 Oct;62(4):452-5.
    Chemical and biologically active constituents of Pteris multifida.[Pubmed: 18553125]
    A new compound, 4-caffeoyl quinic acid 5-O-methyl ether (2), together with 12 known compounds--identified as (2R,3R)-pterosin L 3-O-beta-D-glucopyrannoside (3), beta-sitosterol beta-D-glucopyranoside (4), apigenin 7-O-beta-D-glucopyranoside (5), luteolin 7-O-beta-D-glucopyranoside (6), sucrose (7), caffeic acid (8), pterosin C 3-O-beta-D-glucopyranoside (9), pteroside C (10), 4,5-dicaffeoyl quinic acid (11), Pteroside A (12), wallichoside (13) and (2S)-5,7,3',5'-tetrahydroxyflavanone (14)--were isolated from Pteris multifida.
    METHODS AND RESULTS:
    The structure of the new compound was determined by means of physical, chemical and spectroscopic evidence. Compounds 5 and 6 were the main constituents of the plant, with yields of 0.19% and 0.16%, respectively. The cytotoxic activities of 2, 3, and 9-13 were evaluated against a human cell line (KB cells).
    CONCLUSIONS:
    Among the isolated compounds, pterosin C 3-O-beta-D-glucopyrannoside (9) and 4,5-dicaffeoylquinic acid (11) showed a significant selective cytotoxicity (IC(50) 2.35 and 5.38, respectively), while moderate activity was observed for compound 2 (IC(50) 12.3). The chemosystematics of Pteris species is also discussed.
    Phytochemistry. 2016 Aug;128:82-94.
    Isolation and characterisation of 13 pterosins and pterosides from bracken (Pteridium aquilinum (L.) Kuhn) rhizome.[Pubmed: 27177933 ]
    Systematic phytochemical investigations of the underground rhizome of Pteridium aquilinum (L.) Kuhn (Dennstaedtiaceae) afforded thirty-five pterosins and pterosides.
    METHODS AND RESULTS:
    By detailed analysis of one- and two-dimensional nuclear magnetic resonance spectroscopy, circular dichroism (CD) and high-resolution mass spectrometric data, thirteen previously undescribed pterosins and pterosides have been identified. Interestingly, for the first time 12-O-β-D-glucopyranoside substituted pterosins, rhedynosides C and D, and the sulfate-containing pterosin, rhedynosin H, alongside the two known compounds, histiopterosin A and (2S)-Pteroside A2, were isolated from the rhizomes of subsp. aquilinum of bracken. In addition, six-membered cyclic ether pterosins and pterosides, rhedynosin A and rhedynoside A, are the first examples of this type of pterosin-sesquiterpenoid. Additionally, the three previously reported compounds (rhedynosin I, (2S)-2-hydroxymethylpterosin E and (2S)-12-hydroxypterosin A) were obtained for the first time from plants as opposed to mammalian metabolic products. Single crystal X-ray diffraction analysis was applied to the previously undescribed compounds (2R)-rhedynoside B, (2R)-pteroside B and (2S)-pteroside K, yielding the first crystal structures for pterosides, and three known pterosins, (2S)-pterosin A, trans-pterosin C and cis-pterosin C. Rhedynosin C is the only example of the cyclic lactone pterosins with a keto group at position C-14.
    CONCLUSIONS:
    Six selected pterosins ((2S)-pterosin A, (2R)-pterosin B and trans-pterosin C) and associated glycosides ((2S)-Pteroside A, (2R)-pteroside B and pteroside Z) were assessed for their anti-diabetic activity using an intestinal glucose uptake assay; all were found to be inactive at 300 μM.
    7-(4-Hydroxyphenyl)-1-phenyl-4-hepten-3-one

    Catalog No: CFN95140
    CAS No: 100667-52-5
    Price: $318/5mg
    Saucerneol

    Catalog No: CFN95267
    CAS No: 88497-86-3
    Price: $413/5mg
    Diosniposide B

    Catalog No: CFN95333
    CAS No: N/A
    Price: $413/5mg
    Oblonganoside D

    Catalog No: CFN95460
    CAS No: 943021-91-8
    Price: $318/5mg
    Ganoweberianic acid E

    Catalog No: CFN95504
    CAS No: 1309931-90-5
    Price: $413/5mg
    8-epi-Confertin

    Catalog No: CFN95509
    CAS No: 110115-60-1
    Price: $318/5mg
    (3,4-Dihydroxyphenyl)methyl 3-(beta-D-glucopyranosyloxy)-4-hydroxybenzoate

    Catalog No: CFN95531
    CAS No: 877461-90-0
    Price: $318/10mg
    Apigenin-6-C-beta-D-glucopyranosyl-8-C-[alpha-L-rhamnopyranosyl-(1->2)]-beta-glucopyranoside

    Catalog No: CFN95540
    CAS No: 1646598-06-2
    Price: $368/5mg
    Scoparin

    Catalog No: CFN95544
    CAS No: 301-16-6
    Price: $318/5mg
    Methyl lucidenate E2

    Catalog No: CFN95569
    CAS No: 98665-12-4
    Price: $413/5mg